A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments.
IDIOPATHIC PULMONARY FIBROSIS AND THE EFFECTS OF TREATMENT
The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.
CUROSURF INTRATRACHEAL SUSPENSION
Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, …
Can't Get Enough of XVIVO?
We’ve got you covered! Check out our latest wallpapers for stunning visuals!